Lundbeck/Takeda vortioxetine lifts depression in seniors
This article was originally published in Scrip
Executive Summary
Following on from a US filing for the multimodal antidepressant, vortioxetine (Lu AA21004), for major depressive disorder in adults, Lundbeck and Takeda have unveiled data showing that the drug is efficacious and well tolerated when used to treat elderly patients with recurrent major depressive disorder.